These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 11576026)
1. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026 [TBL] [Abstract][Full Text] [Related]
2. "Ecstasy" and serotonin neurotoxicity: new findings raise more questions. McCann UD; Ricaurte GA; Molliver ME Arch Gen Psychiatry; 2001 Oct; 58(10):907-8. PubMed ID: 11576027 [No Abstract] [Full Text] [Related]
3. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626 [TBL] [Abstract][Full Text] [Related]
5. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248 [TBL] [Abstract][Full Text] [Related]
6. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049 [TBL] [Abstract][Full Text] [Related]
7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479 [TBL] [Abstract][Full Text] [Related]
8. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Curran HV; Verheyden SL Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801 [TBL] [Abstract][Full Text] [Related]
9. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Reneman L; Booij J; Schmand B; van den Brink W; Gunning B Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746 [TBL] [Abstract][Full Text] [Related]
10. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Semple DM; Ebmeier KP; Glabus MF; O'Carroll RE; Johnstone EC Br J Psychiatry; 1999 Jul; 175():63-9. PubMed ID: 10621770 [TBL] [Abstract][Full Text] [Related]
11. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. de Win MM; Reneman L; Reitsma JB; den Heeten GJ; Booij J; van den Brink W Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174 [TBL] [Abstract][Full Text] [Related]
14. In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain. Scheffel U; Szabo Z; Mathews WB; Finley PA; Dannals RF; Ravert HT; Szabo K; Yuan J; Ricaurte GA Synapse; 1998 Jun; 29(2):183-92. PubMed ID: 9593108 [TBL] [Abstract][Full Text] [Related]
15. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713 [TBL] [Abstract][Full Text] [Related]
16. Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. Bosch OG; Wagner M; Jessen F; Kühn KU; Joe A; Seifritz E; Maier W; Biersack HJ; Quednow BB PLoS One; 2013; 8(4):e61234. PubMed ID: 23585882 [TBL] [Abstract][Full Text] [Related]
17. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Reneman L; Booij J; Lavalaye J; de Bruin K; Reitsma JB; Gunning B; den Heeten GJ; van Den Brink W Psychopharmacology (Berl); 2002 Jan; 159(3):335-40. PubMed ID: 11862367 [TBL] [Abstract][Full Text] [Related]
18. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]
19. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Reneman L; Majoie CB; Schmand B; van den Brink W; den Heeten GJ Biol Psychiatry; 2001 Oct; 50(7):550-4. PubMed ID: 11600108 [TBL] [Abstract][Full Text] [Related]
20. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats. Aguirre N; Barrionuevo M; Lasheras B; Del Río J J Pharmacol Exp Ther; 1998 Sep; 286(3):1159-65. PubMed ID: 9732373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]